Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2026-02-20 @ 12:41 PM
Study NCT ID:
NCT02274558
Status:
COMPLETED
Last Update Posted:
2017-07-11
First Post:
2014-10-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 3 Study of NBI-98854 for the Treatment of Tardive Dyskinesia
Sponsor:
Neurocrine Biosciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-10
Start Date Type:
None
Primary Completion Date:
2015-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-07
Completion Date Type:
ACTUAL
First Submit Date:
2014-10-22
First Submit QC Date:
None
Study First Post Date:
2014-10-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-05-11
Results First Submit QC Date:
None
Results First Post Date:
2017-07-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-10-13
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-06-09
Last Update Post Date:
2017-07-11
Last Update Post Date Type:
ACTUAL